Brokerages Anticipate Select Medical Holdings Co. (SEM) Will Post Quarterly Sales of $1.28 Billion

Brokerages predict that Select Medical Holdings Co. (NYSE:SEM) will announce $1.28 billion in sales for the current quarter, according to Zacks. Two analysts have issued estimates for Select Medical’s earnings. Select Medical reported sales of $1.11 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 15.3%. The business is expected to announce its next quarterly earnings results on Wednesday, February 20th.

According to Zacks, analysts expect that Select Medical will report full year sales of $5.09 billion for the current fiscal year. For the next fiscal year, analysts expect that the company will post sales of $5.36 billion, with estimates ranging from $5.26 billion to $5.47 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Select Medical.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, November 1st. The health services provider reported $0.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.05. Select Medical had a net margin of 4.32% and a return on equity of 15.95%. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.28 billion. During the same period last year, the business earned $0.14 EPS. Select Medical’s revenue for the quarter was up 17.7% compared to the same quarter last year.

SEM has been the topic of several research reports. ValuEngine downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, September 12th. Credit Suisse Group raised their price objective on shares of Select Medical from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, November 5th. Finally, Zacks Investment Research raised shares of Select Medical from a “sell” rating to a “hold” rating in a research report on Thursday, October 4th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $20.83.

Select Medical stock traded down $0.18 during midday trading on Friday, hitting $18.41. 491,079 shares of the company’s stock were exchanged, compared to its average volume of 613,745. Select Medical has a 12-month low of $15.83 and a 12-month high of $21.65. The company has a debt-to-equity ratio of 3.72, a quick ratio of 1.49 and a current ratio of 1.49. The company has a market capitalization of $2.51 billion, a P/E ratio of 18.98, a PEG ratio of 1.26 and a beta of 1.43.

In related news, Chairman Robert A. Ortenzio sold 37,468 shares of the business’s stock in a transaction dated Tuesday, November 6th. The shares were sold at an average price of $20.05, for a total transaction of $751,233.40. Following the sale, the chairman now owns 7,251,571 shares of the company’s stock, valued at $145,393,998.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director James S. Ely III sold 9,000 shares of the business’s stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $20.00, for a total transaction of $180,000.00. Following the sale, the director now directly owns 101,865 shares in the company, valued at approximately $2,037,300. The disclosure for this sale can be found here. In the last ninety days, insiders sold 145,044 shares of company stock worth $2,907,682. Insiders own 19.86% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in Select Medical by 0.7% during the third quarter. Vanguard Group Inc. now owns 10,514,877 shares of the health services provider’s stock worth $193,473,000 after buying an additional 77,612 shares in the last quarter. Morgan Stanley raised its position in Select Medical by 146.0% during the third quarter. Morgan Stanley now owns 666,146 shares of the health services provider’s stock worth $12,257,000 after acquiring an additional 395,394 shares during the last quarter. Legal & General Group Plc raised its position in Select Medical by 7.7% during the third quarter. Legal & General Group Plc now owns 295,362 shares of the health services provider’s stock worth $5,411,000 after acquiring an additional 21,076 shares during the last quarter. NorthCoast Asset Management LLC acquired a new position in Select Medical during the third quarter worth about $1,752,000. Finally, Teachers Advisors LLC raised its position in Select Medical by 16.0% during the third quarter. Teachers Advisors LLC now owns 258,245 shares of the health services provider’s stock worth $4,752,000 after acquiring an additional 35,629 shares during the last quarter. 75.45% of the stock is currently owned by hedge funds and other institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

Read More: What is a stock buyback?

Get a free copy of the Zacks research report on Select Medical (SEM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply